Kyberlife, a B2B healthcare e-commerce platform based in Singapore, has raised $3 million in its latest investment round, led by 5I Ventures. Other investors include East Ventures, A2D Ventures, and NUS Alumni Ventures.
The new funding will help it to expand in the region and improve the digital procurement process in healthcare. The company plans to grow in Indonesia, connect local healthcare institutions with global suppliers, and invest in new technologies.
It plans to bring Indonesian vendors onto its platform, helping them expand their business internationally and find new growth opportunities. The company also wants to grow its network of suppliers and customers in Southeast Asia, including Singapore, Indonesia, and Thailand.
By adding new product categories like laboratory instruments and chemical reagents, Kyberlife aims to support local organizations in improving research and development (R&D) for clinical trials and pharmaceutical research in the ASEAN region.
The company hopes to expand its vendor portfolio tenfold in the next three years. Kyberlife will also invest in technologies like artificial intelligence (AI) to offer personalized product recommendations and make procurement processes more efficient and sustainable.
Ryan James Lim, Co-Founder and Chief Executive Officer, Kyberlife said, “Kyberlife is a platform that is built by scientists, for scientists. Our vision is to simplify the complex and lengthy process researchers face when sourcing laboratory equipment and supplies essential for R&D in the healthcare industry, we look forward to connecting more healthcare vendors with institutions to drive R&D efforts in Singapore and in the broader Southeast Asia region,”.
Read also – Equinix has Issued its First Green Bonds in Singapore, Raising $375Million to Support Sustainability Efforts
Kyberlife is a healthcare e-commerce platform that makes it easier to buy medical supplies and pharmaceuticals. Using AI and data analysis, the company connects researchers with reliable suppliers, helping to make the healthcare supply chain more efficient, transparent and cost-effective.
Dieter Schlosser, Managing Partner at 5I Ventures said, “At 5I Ventures, we invest in companies that disrupt industries and provide scalable solutions, Kyberlife’s innovative approach to procurement is a game-changer for the life sciences sector, and we are proud to back their vision,”
Ankit Upadhyay, General Partner of A2D Ventures, said “the firm believes in Kyberlife’s ability to redefine how healthcare institutions, government agencies and laboratories access critical supplies. Their platform’s potential to scale and drive innovation in an industry that impacts millions of lives aligns perfectly with our mission to support transformative startups,”.
Wesley Tay, Principal at East Ventures, also said that the fund believes Kyberlife will make a difference in digitizing and streamlining procurement processes in the healthcare and life sciences space in Southeast Asia and beyond, and at the same time, bring regional healthcare institutions greater access to global suppliers.
About Kyberlife
Kyberlife has the first open marketplace in Asia, offering an easy-to-use platform for healthcare vendors, life-science companies, and manufacturers worldwide. It also has a distribution branch that helps deliver licensed life science, pharmaceutical, and medical products, along with equipment, to the Southeast Asia region.
